EE525 The Economic Value of Insulin Glargine 300 U/Ml (Gla-300) in People ≥18 Years of Age With Type 2 Diabetes Mellitus: A Value-Based Economic Model From a U.S. Payer Perspective

Abstract

Authors

E Ponomareva C Siegfried SSS Srinivas R Preblick S Park L Wilson A Revel

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×